Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...

Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...

In a large-scale diagnostic study, artificial intelligence (AI) assistance led to a superior improvement in prostate cancer detection on MRI, increasing diagnostic accuracy by 3.3% compared with ...

手術や放射線療法など、従来の方法による前立腺がんの治療には一定のリスクがあり、勃起障害、排尿障害、排便障害などの副作用が指摘されています。そこで、MRIと超音波技術を用いた新しい治療法の臨床実験が行われ、「被験者の約80%で有意なレベルで ...

Further research is recommended to determine the impact of MRI fusion biopsy systems compared with cognitive fusion biopsy on the detection of different grades of prostate cancer. Further data ...

Decision making is evidence based and must be shielded from lobbying The NHS draft recommendation against routine prostate ...

Koelis, SAS ('Koelis” or the 'Company”, a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer ...

The phase three clinical trial reached a milestone with its first American participant receiving treatment, advancing ...